Haemoglobin adducts as biomarkers of exposure to tobacco-related nitrosamines

Biomarkers

Volumn 13, Issue 2, 2008, Pages 145-159

  Myers, Steven ^a   Ali, Yeakub M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Biomarkers; Exposure; GC MS; Nitrosoamine haemoglobin adducts; Smoking; Tobacco

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN; METHANE; NICOTINE; NITROSAMINE; TOBACCO SMOKE;

ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DERIVATIZATION; ENVIRONMENTAL EXPOSURE; ERYTHROCYTE; FEMALE; FETUS BLOOD; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; INTERMETHOD COMPARISON; IONIZATION; MASS SPECTROMETRY; MATERNAL BLOOD; MATERNAL SMOKING; NEWBORN; PREGNANCY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

BIOLOGICAL MARKERS; BUTANONES; ENVIRONMENTAL MONITORING; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; HUMANS; PYRIDINES; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 39349083784     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701470561     Document Type: Article

References (44)

1. Acosta, M., Buchhalter, A., Breland, A., Hamilton, D. and Eissenberg, T. (2004) Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: Comparison between gas chromatography/mass spectrometry and immunoassay test strips. Nicotine & Tobacco Research, 64, pp. 615-620.
2. Airoldi, L., Vineis, P., Colombi, A., Olgiati, L., Dell'Osta, C., Fanelli, R., Manzi, L., Veglia, F., Autrup, H. and Dunning, A. (2005) 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiology, Biomarkers & Prevention, 149, pp. 2118-2124.
3. Akiyama, Y., Arashidani, K., Kawano, W. and Kunugita, N. (2006) Urinary nicotine and its metabolites as a biomarker of exposure to environmental tobacco smoke. J UOEH, 283, pp. 245-252.
4. Angerer, J., Ewers, U. and Wilhelm, M. (2007) Human biomonitoring: State of the art. International Journal of Hygiene and Environmental Health, 21034, pp. 201-228.
5. Atawodi, SE, Lea, S., Nyberg, F., Mukeria, A., Constantinescu, V., Ahrens, W., Brueske-Hohlfeld, I., Fortes, C., Boffetta, P. and Friesen, MD (1998) 4-Hydroxy-1-3-pyridyl-1-butanone-hemoglobin adducts as biomarkers of exposure to tobacco smoke: Validation of a method to be used in multicenter studies. Cancer Epidemiology, Biomarkers & Prevention, 79, pp. 817-821.
6. Bader, M., Lehnert, G. and Angerer, J. (1994) GC/MS determination of N-phenylvaline, a possible biomarker for benzene exposure in human hemoglobin by the N-alkyl Edman method. International Archives of Occupational and Environmental Health, 656, pp. 411-414.
7. Bartsch, H., Caporaso, N., Coda, M., Kadlubar, F., Malaveille, C., Skipper, P., Talaska, G., Tannenbaum, SR and Vineis, P. (1990) Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. Journal of the National Cancer Institute, 8223, pp. 1826-1831.
8. Bernert, JT, Jain, RB, Pirkle, JL, Wang, L., Miller, BB and Sampson, EJ (2005) Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine & Tobacco Research, 75, pp. 729-738.
9. Bryan, SM and Hindmarsh, PC (2006) Normal and abnormal fetal growth. Hormone Research, 65, pp. 19-27.
10. Chiolero, A., Bovet, P. and Paccaud, F. (2005) Association between maternal smoking and low birth weight in Switzerland: The EDEN study. Swiss Medical Weekly, 491138:40737, pp. 525-530.
11. Dukic, VM, Niessner, M., Benowitz, N., Hans, S. and Wakschlag, L. (2007) Modeling the relationship of cotinine and self-reported measures of maternal smoking during pregnancy: A deterministic approach. Nicotine & Tobacco Research, 94, pp. 453-465.
12. Ehrenberg, L., Granath, F. and Tornqvist, M. (1996) Macromolecule adducts as biomarkers of exposure to environmental mutagens in human populations. Environmental Health Perspectives, 104, pp. 423-428.
13. Ehrenberg, L. and Tornqvist, M. (1992) Use of biomarkers in epidemiology: Quantitative aspects. Toxicology Letters 64-65 (Spec no).pp. 485-492.
14. Falter, B., Kutzer, C. and Richter, E. (1994) Biomonitoring of hemoglobin adducts: Aromatic amines and tobacco-specific nitrosamines. Clinical Investigations, 725, pp. 364-371.
15. Hammoud, AO, Bujold, E., Sorokin, Y., Schild, C., Krapp, M. and Baumann, P. (2005) Smoking in pregnancy revisited: Findings from a large population-based study. American Journal of Obstetrics & Gynecology 1926:1856-1862; discussion, pp. 1862-1853.
16. Haufroid, V. and Lison, D. (1998) Urinary cotinine as a tobacco-smoke exposure index: A minireview. International Archives of Occupational and Environmental Health, 713, pp. 162-168.
17. Haustein, KO (1999) Cigarette smoking, nicotine and pregnancy. International Journal of Clinical Pharmacology and Therapeutics, 379, pp. 417-427.
18. Hecht, SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews. Cancer, 310, pp. 733-744.
19. Hecht, SS, Carmella, SG and Murphy, SE (1991) Hemoglobin adducts as biomarkers of exposure to and metabolic activation of carcinogenic tobacco-specific nitrosamines. Biomedical and Environmental Sciences, 412, pp. 93-103.
20. Hoffmann, D., Brunnemann, KD, Prokopczyk, B. and Djordjevic, MV (1994) Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. Journal of Toxicology and Environmental Health, 411, pp. 1-52.
21. Hoffmann, D., Rivenson, A., Chung, FL and Hecht, SS (1991) Nicotine-derived N-nitrosamines TSNA and their relevance in tobacco carcinogenesis. Critical Reviews in Toxicology, 214, pp. 305-311.
22. Ingvarsson, RF, Bjarnason, AO, Dagbjartsson, A., Hardardottir, H., Haraldsson, A. and Thorkelsson, T. (2007) The effects of smoking in pregnancy on factors influencing fetal growth. Acta Paediatrica, 963, pp. 383-386.
23. Joseph, AM, Hecht, SS, Murphy, SE, Carmella, SG, Le, CT, Zhang, Y., Han, S. and Hatsukami, DK (2005) Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiology, Biomarkers & Prevention, 1412, pp. 2963-2968.
24. LaVoie, EJ, Stern, SL, Choi, CI, Reinhardt, J. and Adams, JD (1987) Transfer of the tobacco-specific carcinogens N'-nitrosonornicotine and 4-methylnitrosamino-1-3-pyridyl-1-butanone and benzo[a]pyrene into the milk of lactating rats. Carcinogenesis, 83, pp. 433-437.
25. Mansi, G., Raimondi, F., Pichini, S., Capasso, L., Sarno, M., Zuccaro, P., Pacifici, R., Garcia-Algar, O., Romano, A. and Paludetto, R. (2007) Neonatal urinary cotinine correlates with behavioral alterations in newborns prenatally exposed to tobacco smoke. Pediatric Research, 612, pp. 257-261.
26. Matt, GE, Quintana, PJ, Liles, S., Hovell, MF, Zakarian, JM, Jacob, P 3rd and Benowitz, NL. (2006) Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure. Biomarkers
27. Nelson, E., Goubet-Wiemers, C., Guo, Y. and Jodscheit, K. (1999) Maternal passive smoking during pregnancy and foetal developmental toxicity. Part 2: Histological changes. Human & Experimental Toxicology, 184, pp. 257-264.
28. Nelson, E., Jodscheit, K. and Guo, Y. (1999) Maternal passive smoking during pregnancy and fetal developmental toxicity. Part 1: Gross morphological effects. Human & Experimental Toxicology, 184, pp. 252-256.
29. Obed, S. and Patience, A. (2006) Birth weight and ponderal index in pre-eclampsia: A comparative study. Ghana Medical Journal, 401, pp. 8-13.
30. Ogawa, M., Oyama, T., Isse, T., Yamaguchi, T., Murakami, T., Endo, Y. and Kawamoto, T. (2006) Hemoglobin adducts as a marker of exposure to chemical substances, especially PRTR class I designated chemical substances. Journal of Occupational Health, 485, pp. 314-328.
31. Okoli, CT, Kelly, T. and Hahn, EJ. (2007) Secondhand smoke and nicotine exposure: A brief review. Addictive Behavior, 32, pp. 1977-1988.
32. Osterman-Golkar, S. and Bond, JA (1996) Biomonitoring of 1,3-butadiene and related compounds. Environmental Health Perspective, 104, pp. 907-915.
33. Reckzeh, G., Dontewill, W. and Leuschner, F. (1975) Testing of cigarette smoke inhalation for teratogenicity in rats. Toxicology, 43, pp. 289-295.
34. Richter, E. and Branner, B. (2002) Biomonitoring of exposure to aromatic amines: Haemoglobin adducts in humans. Journal of Chromatography. B. Analytical Technologies in the Biomedical and Life Sciences, 77812, pp. 49-62.
35. Rodriguez, JW, Kirlin, WG, Wirsiy, YG, Matheravidathu, S., Hodge, TW and Urso, P. (1999) Maternal exposure to benzo[a]pyrene alters development of T lymphocytes in offspring. Immunopharmacology and Immunotoxicology, 212, pp. 379-396.
36. Sabbioni, G., Jones, CR, Sepai, O., Hirvonen, A., Norppa, H., Jarventaus, H., Glatt, H., Pomplun, D., Yan, H., Brooks, LR, Warren, SH, Demarini, DM and Liu, YY (2006) Biomarkers of exposure, effect, and susceptibility in workers exposed to nitrotoluenes. Cancer Epidemiology, Biomarkers & Prevention, 153, pp. 559-566.
37. Sardas, S., Karahalil, B., Akyol, D., Kukner, S. and Karakaya, AE (1995) The effect of smoking on sister chromatid exchange rate of newborn infants born to smoking mothers. Mutation Research, 3414, pp. 249-253.
38. Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D. and Riedel, K. (2007) Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regulatory Toxicology and Pharmacology, 472, pp. 171-183.
39. Scherer, G., Frank, S., Riedel, K., Meger-Kossien, I. and Renner, T. (2000) Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiology, Biomarkers & Prevention, 94, pp. 373-380.
40. Smith, CJ, Sears, SB, Walker, JC and DeLuca, PO. (1992) Environmental tobacco smoke: Current assessment and future directions. Toxicologic Pathology 202:289-303; discussion.pp. 303-285.
41. Sorensen, M., Bisgaard, H., Stage, M. and Loft, S. (2007) Biomarkers of exposure to environmental tobacco smoke in infants. Biomarkers, 121, pp. 38-46.
42. Tannenbaum, SR (1990) Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology. Princess Takamatsu Symposia, 21, pp. 351-360.
43. Tulunay, OE, Hecht, SS, Carmella, SG, Zhang, Y., Lemmonds, C., Murphy, S. and Hatsukami, DK (2005) Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiology, Biomarkers & Prevention, 145, pp. 1283-1286.
44. Wu, KY, Chiang, SY, Huang, TH, Tseng, YS, Chen, YL, Kuo, HW and Hsieh, CL (2004) Formation of N-2-hydroxyethylvaline in human hemoglobin-effect of lifestyle factors. Mutation Research, 55912, pp. 73-82.